Los Angeles Capital Management LLC Innoviva, Inc. Transaction History

Los Angeles Capital Management LLC

$22.3 Billion
Q1 2025

A detailed history of Los Angeles Capital Management LLC transactions in Innoviva, Inc. stock. As of the latest transaction made, Los Angeles Capital Management LLC holds 51,025 shares of INVA stock, worth $977,128. This represents 0.0% of its overall portfolio holdings.

Number of Shares

51,025

Previous 40,735 25.26%

Holding current value

$977,128

Previous $706,000 31.02%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 05, 2025	BUY	$17.21 - $18.98 $177,090 - $195,304	10,290 Added 25.26%	51,025 $925,000
Q3 2024 Nov 04, 2024	BUY	$16.33 - $20.04 $295,099 - $362,142	18,071 Added 79.73%	40,735 $786,000
Q2 2024 Aug 05, 2024	SELL	$14.4 - $16.4 $1.63 Million - $1.86 Million	-113,530 Reduced 83.36%	22,664 $371,000
Q1 2024 Apr 05, 2024	SELL	$14.56 - $16.78 $327,075 - $376,945	-22,464 Reduced 14.16%	136,194 $2.08 Million
Q4 2023 Feb 06, 2024	SELL	$12.32 - $16.27 $226,675 - $299,351	-18,399 Reduced 10.39%	158,658 $2.54 Million
Q3 2023 Nov 06, 2023	BUY	$12.37 - $13.89 $9,425 - $10,584	762 Added 0.43%	177,057 $2.3 Million
Q2 2023 Aug 03, 2023	BUY	$11.39 - $13.72 $122,966 - $148,121	10,796 Added 6.52%	176,295 $2.24 Million
Q1 2023 May 04, 2023	SELL	$10.73 - $13.6 $198,601 - $251,722	-18,509 Reduced 10.06%	165,499 $1.86 Million
Q4 2022 Feb 06, 2023	SELL	$11.8 - $13.78 $18,809 - $21,965	-1,594 Reduced 0.86%	184,008 $2.44 Million
Q3 2022 Nov 02, 2022	SELL	$11.61 - $15.22 $957,755 - $1.26 Million	-82,494 Reduced 30.77%	185,602 $2.16 Million
Q2 2022 Aug 05, 2022	BUY	$14.32 - $19.88 $27,236 - $37,811	1,902 Added 0.71%	268,096 $3.96 Million
Q1 2022 May 06, 2022	BUY	$15.39 - $20.25 $820,671 - $1.08 Million	53,325 Added 25.05%	266,194 $5.15 Million
Q4 2021 Feb 03, 2022	BUY	$15.91 - $18.72 $263,771 - $310,358	16,579 Added 8.45%	212,869 $3.67 Million
Q3 2021 Nov 08, 2021	SELL	$13.06 - $17.24 $544,667 - $718,994	-41,705 Reduced 17.52%	196,290 $3.28 Million
Q2 2021 Aug 05, 2021	BUY	$11.45 - $13.96 $1.11 Million - $1.36 Million	97,156 Added 68.98%	237,995 $3.19 Million
Q1 2021 May 05, 2021	BUY	$11.06 - $12.87 $778,524 - $905,932	70,391 Added 99.92%	140,839 $1.68 Million
Q4 2020 Feb 04, 2021	BUY	$9.33 - $12.48 $538,415 - $720,195	57,708 Added 452.97%	70,448 $873,000
Q3 2020 Nov 02, 2020	SELL	$10.33 - $14.49 $171,478 - $240,534	-16,600 Reduced 56.58%	12,740 $133,000
Q2 2020 Aug 05, 2020	BUY	$11.49 - $15.26 $108,752 - $144,435	9,465 Added 47.62%	29,340 $410,000
Q1 2020 May 04, 2020	BUY	$8.11 - $15.23 $161,186 - $302,696	19,875 New	19,875 $234,000
Q2 2018 Jul 31, 2018	SELL	$13.44 - $17.59 $1.57 Million - $2.05 Million	-116,762 Closed	0 $0
Q1 2018 Apr 27, 2018	SELL	$13.8 - $16.99 $990,136 - $1.22 Million	-71,749 Reduced 38.06%	116,762 $1.95 Million
Q4 2017 Feb 05, 2018	BUY	$11.73 - $14.75 $2.21 Million - $2.78 Million	188,511	188,511 $2.68 Million

Others Institutions Holding INVA

# of Institutions

256

Shares Held

75M

Call Options Held

2.3K

Put Options Held

2.4K

View Full List

About Innoviva, Inc.

Ticker INVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,706,000
Market Cap $1.33B
Description
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...

More about INVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Los Angeles Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Los Angeles Capital Management LLC with notifications on news.

Account

Los Angeles Capital Management LLC Innoviva, Inc. Transaction History